J M Karon1, P L Fleming, R W Steketee, K M De Cock. 1. National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention (CDC), Atlanta, Ga., USA. jkaron@cdc.gov
Abstract
OBJECTIVES: The current status of and changes in the HIV epidemic in the United States are described. METHODS: Surveillance data were used to evaluate time trends in AIDS diagnoses and deaths. Estimates of HIV incidence were derived from studies done during the 1990s; time trends in recent HIV incidence were inferred from HIV diagnoses and seroprevalence rates among young persons. RESULTS: Numbers of deaths and AIDS diagnoses decreased dramatically during 1996 and 1997 but stabilized or declined only slightly during 1998 and 1999. Proportional decreases were smallest among African American women, women in the South, and persons infected through heterosexual contact, HIV incidence has been roughly constant since 1992 in most populations with time trend data, remains highest among men who have sex with men and injection drug users, and typically is higher among African Americans than other racial/ethnic groups. CONCLUSIONS: The epidemic increasingly affects women minorities, persons infected through heterosexual contact, and the poor. Renewed interest and investment in HIV and AIDS surveillance and surveillance of behaviors associated with HIV transmission are essential to direct resources for prevention to populations with greatest need and to evaluate intervention programs.
OBJECTIVES: The current status of and changes in the HIV epidemic in the United States are described. METHODS: Surveillance data were used to evaluate time trends in AIDS diagnoses and deaths. Estimates of HIV incidence were derived from studies done during the 1990s; time trends in recent HIV incidence were inferred from HIV diagnoses and seroprevalence rates among young persons. RESULTS: Numbers of deaths and AIDS diagnoses decreased dramatically during 1996 and 1997 but stabilized or declined only slightly during 1998 and 1999. Proportional decreases were smallest among African American women, women in the South, and persons infected through heterosexual contact, HIV incidence has been roughly constant since 1992 in most populations with time trend data, remains highest among men who have sex with men and injection drug users, and typically is higher among African Americans than other racial/ethnic groups. CONCLUSIONS: The epidemic increasingly affects women minorities, persons infected through heterosexual contact, and the poor. Renewed interest and investment in HIV and AIDS surveillance and surveillance of behaviors associated with HIV transmission are essential to direct resources for prevention to populations with greatest need and to evaluate intervention programs.
Authors: S Schwarcz; T Kellogg; W McFarland; B Louie; R Kohn; M Busch; M Katz; G Bolan; J Klausner; H Weinstock Journal: Am J Epidemiol Date: 2001-05-15 Impact factor: 4.897
Authors: T Diaz; S Y Chu; J W Buehler; D Boyd; P J Checko; L Conti; A J Davidson; P Hermann; M Herr; A Levy Journal: Am J Prev Med Date: 1994 Jul-Aug Impact factor: 5.043
Authors: D S Metzger; G E Woody; A T McLellan; C P O'Brien; P Druley; H Navaline; D DePhilippis; P Stolley; E Abrutyn Journal: J Acquir Immune Defic Syndr (1988) Date: 1993-09
Authors: P M Wortley; S Y Chu; T Diaz; J W Ward; B Doyle; A J Davidson; P J Checko; M Herr; L Conti; S A Fann Journal: AIDS Date: 1995-05 Impact factor: 4.177
Authors: Scott E Hadland; M-J Milloy; Thomas Kerr; Ruth Zhang; Silvia Guillemi; Robert S Hogg; Julio S Montaner; Evan Wood Journal: AIDS Patient Care STDS Date: 2012-03-19 Impact factor: 5.078
Authors: Robert S Levine; Nathaniel C Briggs; Barbara S Kilbourne; William D King; Yvonne Fry-Johnson; Peter T Baltrus; Baqar A Husaini; George S Rust Journal: Am J Public Health Date: 2007-08-29 Impact factor: 9.308
Authors: Evan Wood; Julio S G Montaner; Benita Yip; Mark W Tyndall; Martin T Schechter; Michael V O'Shaughnessy; Robert S Hogg Journal: CMAJ Date: 2003-09-30 Impact factor: 8.262
Authors: Stephen A Maisto; Michael P Carey; Kate B Carey; Christopher M Gordon; Jennifer L Schum Journal: Exp Clin Psychopharmacol Date: 2004-11 Impact factor: 3.157